0 NASDAQ Companies - September 12, 2019Adverum Biotechnologies Reports Positive 24-Week Data from First Cohort of OPTIC Phase 1 Trial of ADVM-022 Intravitreal Gene Therapy to Treat Wet AMDRead More
0 NASDAQ Companies - September 12, 2019Nano Dimension Presents Production-Grade Printed Capacitors for PCBsRead More
0 NASDAQ Companies - September 12, 2019Fate Therapeutics Announces Pricing of Public Offering of Common StockRead More
0 Canadian Stock Exchange News - September 12, 2019Nabis Holdings Launches BIS, A New CBD Exclusive BrandRead More
